4- (dodecyldimethylammonium)- 1- oxyl- 2,2,6,6- tetramethylpiperidine (CAT(12))
Also Known As:
CAT(12); DDAOTP; 1-Piperidinyloxy, 4-(dodecyldimethylammonio)-2,2,6,6-tetramethyl-, bromide
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Ahmad, Usman:
1 article
(06/2022)
|
| 2. | Alkhayru, Ali:
1 article
(06/2022)
|
| 3. | Degheim, George:
1 article
(06/2022)
|
| 4. | Ebrahimi, Ali:
1 article
(06/2022)
|
| 5. | Hughes, John:
1 article
(06/2022)
|
| 6. | Jabbar, Ali Abdul:
1 article
(06/2022)
|
| 7. | Thompson, Luke:
1 article
(06/2022)
|
| 8. | Cleff, Marlete Brum:
1 article
(03/2021)
|
| 9. | Conceição, Fabrício Rochedo:
1 article
(03/2021)
|
| 10. | Ferreira, Marcos Roberto Alves:
1 article
(03/2021)
|
Related Diseases
| 1. | Thrombosis (Thrombus)
|
| 2. | Ischemia
|
| 3. | Infections
03/01/2021
- " High doses (25-100 mg/kg/day) of ITZ for up to 4 months (03/12, cats 2, 6, 12) or over 12 months (05/12, cats 1, 5, 7, 8, 11) did not provide a clinical cure, except for the association of ITZ plus potassium iodide (01/12, cat 12) for 3 months, which proved useful in infections with itraconazole-resistant S. "
|
| 4. | COVID-19
|
|
Related Drugs and Biologics
Related Therapies and Procedures